Topic: National Cancer Research Network
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed or relapsed patients with cancer starting chemotherapy or multimodality treatment 2. Expected to attend the clinic at least 3times after the initial baseline visit; 3. Able and willing to give informed consent 4. Not taking part in other QL studies run by the Unit 5. Able to read and understand English 6. Not exhibiting overt psychopathology or serious cognitive dysfunction which would impede their being able to take part in the study 7. Either sex, lower age limit of 18 years
Exclusion criteria
Exclusion criteria: Does not meet the exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Content of communication, measured at baseline and for a further three visits 2. Functional Assessment of Cancer Therapy General Scale (FACT-G), measured at baseline and at the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Other process measures (symptomatic drugs, tests, referrals), collected at baseline and for the next three visits 2. Patient-related outcomes (continuity of care and patient satisfaction), collected at baseline and at the end of the study 3. Descriptive information on patient views and attitudes regarding regular QOL data collection, collected at the end of the study | — |
Countries
United Kingdom